Patient satisfaction with Toujeo (insulin glargine 300 Units/mL) in adults with T2D

Prescribing Information can be found through the links in the Product Cards at the bottom of the page

MAGE: patient satisfaction

MAGE was a real-world study investigating patient satisfaction in patients with T2D receiving Toujeo^®.

There was an improvement of at least 2 points in DTSQ score at Month 6 from baseline, meeting the primary endpoint of the study.²

MAGE was a 6-month, multicentre, prospective, single-arm, observational, real-world study (conducted in Belgium) following 87 people with T2D who had been receiving basal and mealtime insulin for ≥6 months.

Primary endpoint: change in DTSQ total score (baseline to Month 6).²

DTSQ: Diabetes Treatment Satisfaction Questionnaire.

Diabetes Products